GILEAD SCIENCES, INC. Long-Term Concentrated

Location: Foster City, CA

CIK: 0000882095 · Show all filings

Period: Q1 2026 (← Previous) (Next →)

Filing Date: May 8, 2026

Total Value: $2.118B (100.0% shares, 0.0% debt)

Holdings (6)

ACLX Arcellx Inc 36.4%

Value $772M Shares 6,720,803 Est. Cost $86.39 Unrealized -17.5%

RCUS Arcus Biosciences Inc 32.1%

Value $679M Shares 31,424,760 Est. Cost $16.13 Unrealized +31.9%

GLPG Galapagos NV 23.7%

Value $501M Shares 16,707,477 Est. Cost $27.64 Unrealized —

ASMB Assembly Biosciences Inc 5.9%

Value $125M Shares 4,505,391 Est. Cost $19.07 Unrealized +49.5%

KYTX Kyverna Therapeutics Inc 1.7%

Value $35.61M Shares 4,126,119 Est. Cost $4.79 Unrealized +73.3%

XLO Xilio Therapeutics Inc 0.3%

Value $5.47M Shares 650,389 Est. Cost $0.98 Unrealized -38.5%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ACLX	Arcellx Inc	6,720,803	$772M	36.4%	$86.39	-17.5%	COM	03940C100
RCUS	Arcus Biosciences Inc	31,424,760	$679M	32.1%	$16.13	+31.9%	COM	03969F109
GLPG	Galapagos NV	16,707,477	$501M	23.7%	$27.64	—	SPON ADR	36315X101
ASMB	Assembly Biosciences Inc	4,505,391	$125M	5.9%	$19.07	+49.5%	COM NEW	045396207
KYTX	Kyverna Therapeutics Inc	4,126,119	$35.61M	1.7%	$4.79	+73.3%	COM	501976104
XLO	Xilio Therapeutics Inc	650,389	$5.47M	0.3%	$0.98	-38.5%	COM	98422T100